Skip to main content
Top
Published in: Calcified Tissue International 6/2015

01-06-2015 | Original Research

Systemic Administration of Lithium Improves Distracted Bone Regeneration in Rats

Authors: Xuemei Wang, Songsong Zhu, Xiaowen Jiang, Yunfeng Li, Donghui Song, Jing Hu

Published in: Calcified Tissue International | Issue 6/2015

Login to get access

Abstract

Lithium, popular in psychology field, has been recognized as an activator component of the canonical Wnt signaling pathway. The effect of lithium on osteogenesis or on the human fracture risk has been widely reported. However, little is known on its role in distraction osteogenesis to date. In this study, the effect of systematic administrated lithium on distraction osteogenesis in a rat model was investigated. The osteotomy was performed on the right tibia in 40 adult male Sprague-Dawley rats. Then they were randomly assigned into two equal groups (n = 20/group), which underwent Lithium or saline treatment through gastric gavage until the day they were killed. One week after the osteotomy, the tibias were distracted for 14 days (rate 0.6 mm/day). Following 8 weeks consolidation period, the distracted tibias in both groups were harvested and examined by X-ray plain radiography, histology, dual-energy X-ray absorptiometry, Micro-CT, and biomechanical tests. The results showed that lithium group possessed higher bone mineral density, more mature new bone tissue, and better regenerated bone mass continuity in the distraction gaps without any local or systemic adverse effects was encountered. This study suggested lithium could increase bony callus ossification volume and accelerate distracted tissue mineralization to facilitate bone regeneration in distraction gap.
Literature
1.
go back to reference Amir LR, Everts V, Bronckers A (2009) Bone regeneration during distraction osteogenesis. Odontology 97:63–75CrossRefPubMed Amir LR, Everts V, Bronckers A (2009) Bone regeneration during distraction osteogenesis. Odontology 97:63–75CrossRefPubMed
2.
3.
go back to reference Aronson J, Rock L (1997) Limb-lengthening, skeletal reconstruction, and bone transport with the Ilizarov method. J Bone Joint Surg Am 79A:1243–1258 Aronson J, Rock L (1997) Limb-lengthening, skeletal reconstruction, and bone transport with the Ilizarov method. J Bone Joint Surg Am 79A:1243–1258
4.
go back to reference Aronson J (1994) Temporal and spatial increases in blood flow during distraction osteogenesis. Clin Orthop 301:124–131PubMed Aronson J (1994) Temporal and spatial increases in blood flow during distraction osteogenesis. Clin Orthop 301:124–131PubMed
5.
go back to reference Hu J, Qi MC, Zou SJ, Li JH, Luo E (2007) Callus formation enhanced by BMP-7 ex vivo gene therapy during distraction osteogenesis in rats. J Orthop Res 25:241–251CrossRefPubMed Hu J, Qi MC, Zou SJ, Li JH, Luo E (2007) Callus formation enhanced by BMP-7 ex vivo gene therapy during distraction osteogenesis in rats. J Orthop Res 25:241–251CrossRefPubMed
6.
go back to reference Li G, Bouxsein ML, Luppen C, Li XJ, Wood M, Seeherman HJ, Wozney JM, Simpson H (2002) Bone consolidation is enhanced by rhBMP-2 in a rabbit model of distraction osteogenesis. J Orthop Res 20:779–788CrossRefPubMed Li G, Bouxsein ML, Luppen C, Li XJ, Wood M, Seeherman HJ, Wozney JM, Simpson H (2002) Bone consolidation is enhanced by rhBMP-2 in a rabbit model of distraction osteogenesis. J Orthop Res 20:779–788CrossRefPubMed
7.
go back to reference Li G, Ryaby JT, Carney DH, Wang H (2005) Bone formation is enhanced by thrombin-related peptide TP508 during distraction osteogenesis. J Orthop Res 23:196–202CrossRefPubMed Li G, Ryaby JT, Carney DH, Wang H (2005) Bone formation is enhanced by thrombin-related peptide TP508 during distraction osteogenesis. J Orthop Res 23:196–202CrossRefPubMed
8.
go back to reference Seebach C, Skripitz R, Andreassen TT, Aspenberg P (2004) Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 22:472–478CrossRefPubMed Seebach C, Skripitz R, Andreassen TT, Aspenberg P (2004) Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 22:472–478CrossRefPubMed
9.
go back to reference Carney SM, Goodwin GM (2005) Lithium—a continuing story in the treatment of bipolar disorder. Acta Psychiat Scand 111:7–12CrossRef Carney SM, Goodwin GM (2005) Lithium—a continuing story in the treatment of bipolar disorder. Acta Psychiat Scand 111:7–12CrossRef
10.
go back to reference Young AH, Newham JI (2006) Lithium in maintenance therapy for bipolar disorder. J Psychopharmacol 20:17–22CrossRefPubMed Young AH, Newham JI (2006) Lithium in maintenance therapy for bipolar disorder. J Psychopharmacol 20:17–22CrossRefPubMed
11.
go back to reference Vestergaard P, Rejnmark L, Mosekilde L (2005) Reduced relative risk of fractures among users of lithium. Calcified Tissue Int 77:1–8CrossRef Vestergaard P, Rejnmark L, Mosekilde L (2005) Reduced relative risk of fractures among users of lithium. Calcified Tissue Int 77:1–8CrossRef
12.
go back to reference Wilting I, de Vries F, Thio B, Cooper C, Heerdink ER, Leutkens HGM, Nolen WA, Egberts ACG, van Staa TP (2007) Lithium use and the risk of fractures. Bone 40:1252–1258CrossRefPubMed Wilting I, de Vries F, Thio B, Cooper C, Heerdink ER, Leutkens HGM, Nolen WA, Egberts ACG, van Staa TP (2007) Lithium use and the risk of fractures. Bone 40:1252–1258CrossRefPubMed
13.
go back to reference Clement-Lacroix P, Ai MR, Morvan F, Roman-Roman S, Vayssiere B, Belleville C, Estrera K, Warman ML, Baron R, Rawadi G (2005) Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci USA 102:17406–17411CrossRefPubMedCentralPubMed Clement-Lacroix P, Ai MR, Morvan F, Roman-Roman S, Vayssiere B, Belleville C, Estrera K, Warman ML, Baron R, Rawadi G (2005) Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci USA 102:17406–17411CrossRefPubMedCentralPubMed
14.
go back to reference Warden SJ, Hassett SM, Bond JL, Rydberg J, Grogg JD, Hilles EL, Bogenschutz ED, Smith HD, Fuchs RK, Bliziotes MM, Turner CH (2010) Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels. Bone 46:985–992CrossRefPubMedCentralPubMed Warden SJ, Hassett SM, Bond JL, Rydberg J, Grogg JD, Hilles EL, Bogenschutz ED, Smith HD, Fuchs RK, Bliziotes MM, Turner CH (2010) Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels. Bone 46:985–992CrossRefPubMedCentralPubMed
15.
16.
go back to reference Bain G, Muller T, Wang X, Papkoff J (2003) Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem Biophys Res Commun 301:84–91CrossRefPubMed Bain G, Muller T, Wang X, Papkoff J (2003) Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem Biophys Res Commun 301:84–91CrossRefPubMed
17.
go back to reference Kugimiya F, Kawaguchi H, Ohba S, Kawamura N, Hirata M, Chikuda H, Azuma Y, Woodgett JR, Nakamura K, Chung U (2007) GSK-3 beta controls osteogenesis through regulating Runx2 activity. PLoS One 9:e837CrossRef Kugimiya F, Kawaguchi H, Ohba S, Kawamura N, Hirata M, Chikuda H, Azuma Y, Woodgett JR, Nakamura K, Chung U (2007) GSK-3 beta controls osteogenesis through regulating Runx2 activity. PLoS One 9:e837CrossRef
18.
go back to reference Chappard D, Baslé MF, Legrand E, Audran M (2011) New laboratory tools in the assessment of bone quality. Osteoporos Int 22:2225–2240CrossRefPubMed Chappard D, Baslé MF, Legrand E, Audran M (2011) New laboratory tools in the assessment of bone quality. Osteoporos Int 22:2225–2240CrossRefPubMed
19.
go back to reference Wang JF, Chen B, Young LT (1999) Identification of a novel lithium regulated gene in rat brain. Mol Brain Res 70:66–73CrossRefPubMed Wang JF, Chen B, Young LT (1999) Identification of a novel lithium regulated gene in rat brain. Mol Brain Res 70:66–73CrossRefPubMed
20.
go back to reference Gundberg CM, Clough ME, Carpenter TO (1992) Development and validation of a radioimmunoassay for mouse osteocalcin—paradoxical response in the hyp mouse. Endocrinology 130:1909–1915PubMed Gundberg CM, Clough ME, Carpenter TO (1992) Development and validation of a radioimmunoassay for mouse osteocalcin—paradoxical response in the hyp mouse. Endocrinology 130:1909–1915PubMed
21.
go back to reference Hahn M, Vogel M, Delling G (1991) Undecalcified preparation of bone tissue—report of technical experience and development of new methods. Virchows Arch 418:1–7CrossRef Hahn M, Vogel M, Delling G (1991) Undecalcified preparation of bone tissue—report of technical experience and development of new methods. Virchows Arch 418:1–7CrossRef
23.
go back to reference Al-Aql ZS, Alagl AS, Graves DT, Gerstenfeld LC, Einhorn TA (2008) Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87:107–118CrossRef Al-Aql ZS, Alagl AS, Graves DT, Gerstenfeld LC, Einhorn TA (2008) Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87:107–118CrossRef
24.
go back to reference Wang H, Sun W, Ma JQ, Pan YC, Wang L, Zhang WB (2014) Polycystin-1 mediates mechanical strain-induced osteoblastic mechanoresponses via potentiation of intracellular calcium and Akt/β-catenin pathway. PLoS One 9:e91730CrossRefPubMedCentralPubMed Wang H, Sun W, Ma JQ, Pan YC, Wang L, Zhang WB (2014) Polycystin-1 mediates mechanical strain-induced osteoblastic mechanoresponses via potentiation of intracellular calcium and Akt/β-catenin pathway. PLoS One 9:e91730CrossRefPubMedCentralPubMed
25.
go back to reference Tang GH, Xu J, Chen RJ, Qian YF, Shen G (2011) Lithium delivery enhances bone growth during midpalatal expression. J Dent Res 90:1246–1252CrossRefPubMed Tang GH, Xu J, Chen RJ, Qian YF, Shen G (2011) Lithium delivery enhances bone growth during midpalatal expression. J Dent Res 90:1246–1252CrossRefPubMed
26.
go back to reference Aronson J, Shen XC, Skinner RA, Hogue WR, Badger TM, Lumpkin CK (1997) Rat model of distraction osteogenesis. J Orthop Res 15:221–226CrossRefPubMed Aronson J, Shen XC, Skinner RA, Hogue WR, Badger TM, Lumpkin CK (1997) Rat model of distraction osteogenesis. J Orthop Res 15:221–226CrossRefPubMed
27.
go back to reference Choi IH, Ahn JH, Chung CY, Cho TJ (2000) Vascular proliferation and blood supply during distraction osteogenesis: a scanning electron microscopic observation. J Orthop Res 18:698–705CrossRefPubMed Choi IH, Ahn JH, Chung CY, Cho TJ (2000) Vascular proliferation and blood supply during distraction osteogenesis: a scanning electron microscopic observation. J Orthop Res 18:698–705CrossRefPubMed
28.
go back to reference Grandjean EM, Aubry JM (2009) Lithium: updated human knowledge using an evidence-based approach. CNS Drugs 23:397–418CrossRefPubMed Grandjean EM, Aubry JM (2009) Lithium: updated human knowledge using an evidence-based approach. CNS Drugs 23:397–418CrossRefPubMed
29.
go back to reference Boton R, Gaviria M, Batlle DC (1987) Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium-therapy. Am J Kidney Dis 10:329–345CrossRefPubMed Boton R, Gaviria M, Batlle DC (1987) Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium-therapy. Am J Kidney Dis 10:329–345CrossRefPubMed
31.
go back to reference Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei QX, Poon R, Alman BA (2007) Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLOS Med 4:1216–1229CrossRef Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei QX, Poon R, Alman BA (2007) Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLOS Med 4:1216–1229CrossRef
32.
go back to reference Cohen Y, Chetrit A, Cohen Y, Sirota P, Modan B (1998) Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment. Med Oncol 15:32–36CrossRefPubMed Cohen Y, Chetrit A, Cohen Y, Sirota P, Modan B (1998) Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment. Med Oncol 15:32–36CrossRefPubMed
33.
go back to reference Heo JS, Lee SY, Lee JC (2010) Wnt/beta-catenin signaling enhances osteoblastogenic differentiation from human periodontal ligament fibroblasts. Mol Cell 30:449–454CrossRef Heo JS, Lee SY, Lee JC (2010) Wnt/beta-catenin signaling enhances osteoblastogenic differentiation from human periodontal ligament fibroblasts. Mol Cell 30:449–454CrossRef
34.
go back to reference Kirton JP, Crofts NJ, George SJ, Brennan K, Canfield AE (2007) Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes—potential relevance to vascular disease? Circ Res 101:581–589CrossRefPubMed Kirton JP, Crofts NJ, George SJ, Brennan K, Canfield AE (2007) Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes—potential relevance to vascular disease? Circ Res 101:581–589CrossRefPubMed
35.
go back to reference Akesson K, Vergnaud Ph, Delmas PD, Obrant KJ (1995) Serum osteocalcin increases during fracture healing in elderly women with hip farcture. Bone 16:427–430PubMed Akesson K, Vergnaud Ph, Delmas PD, Obrant KJ (1995) Serum osteocalcin increases during fracture healing in elderly women with hip farcture. Bone 16:427–430PubMed
36.
go back to reference Hoang MV, Smith LEH, Senger DR (2010) Moderate GSK-3 beta inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy. Angio 13:269–277 Hoang MV, Smith LEH, Senger DR (2010) Moderate GSK-3 beta inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy. Angio 13:269–277
37.
go back to reference Zerlin M, Julius MA, Kitajewski J (2008) Wnt/frizzled signaling in angiogenesis. Angio 11:63–69 Zerlin M, Julius MA, Kitajewski J (2008) Wnt/frizzled signaling in angiogenesis. Angio 11:63–69
38.
go back to reference Masckauchan THN, Kitajewski J (2006) Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight. Physiology 21:181–188CrossRefPubMed Masckauchan THN, Kitajewski J (2006) Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight. Physiology 21:181–188CrossRefPubMed
39.
go back to reference Guo SZ, Arai K, Stins MF, Chuang DM, Lo EH (2009) Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes. Stroke 40:652–655CrossRefPubMedCentralPubMed Guo SZ, Arai K, Stins MF, Chuang DM, Lo EH (2009) Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes. Stroke 40:652–655CrossRefPubMedCentralPubMed
40.
go back to reference Silva R, Martins L, Longatto-Filho A, Almeida OFX, Sousa N (2007) Lithium prevents stress-induced reduction of vascular endothelium growth factor levels. Neurosci Lett 429:33–38CrossRefPubMed Silva R, Martins L, Longatto-Filho A, Almeida OFX, Sousa N (2007) Lithium prevents stress-induced reduction of vascular endothelium growth factor levels. Neurosci Lett 429:33–38CrossRefPubMed
Metadata
Title
Systemic Administration of Lithium Improves Distracted Bone Regeneration in Rats
Authors
Xuemei Wang
Songsong Zhu
Xiaowen Jiang
Yunfeng Li
Donghui Song
Jing Hu
Publication date
01-06-2015
Publisher
Springer US
Published in
Calcified Tissue International / Issue 6/2015
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-0004-7

Other articles of this Issue 6/2015

Calcified Tissue International 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.